About KARYON BIO
Karyon Bio is a Silicon Valley-based company leveraging AI and multi-omics technologies to revolutionize liver disease diagnosis and treatment, focusing on early detection of metabolic dysfunction-associated steatotic liver disease (MASLD).
AI-driven healthcare solutions for liver disease detection and managementIntegration of multi-omics, imaging, clinical, and EHR data for holistic diagnosticsProprietary AI platform using machine learning for analyzing clinical data and biomedical literatureDevelopment of early biomarker detection and personalized treatment plansUtilization of advanced biological methods such as single-cell transcriptomics, 3D organoids, and CRISPR-based screens
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to KARYON BIO right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.